Ebrantil 50 mg, Injektionslösung

7680444860328 CH-44486 Injektionslösung
Ebrantil 50 mg, Injektionslösung
Ebrantil 50 mg, Injektionslösung
Ebrantil 50 mg, Injektionslösung
1 / 3
google

Article details

Package size
5 x 10 ml
Selling units
5
Measure
Ampulle(n)
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
26/02/2025
Summary of Product Characteristics
Français
26/02/2025
Summary of Product Characteristics
Italien
26/02/2025

Detailed composition

Substance Quantity Type Category
(N/A)
50.0 MG Substance Wirkstoff (Principe actif)
(N/A)
50.47 MG Substance WIZUS
(N/A)
1000.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
3.814 MG Substance HBESI

Authorization holder

Cheplapharm Schweiz GmbH

4102 Binningen

Authorization information

Swissmedic authorization number
44486
Drug name
Ebrantil, Injektionslösung
Galenic form
LSPA
ATC Code
C02CA06
Authorization status
Z
Dispensing category
B
First authorization
21/07/1983
Authorization expiration date
31/12/9999
IT Number
02.07.1.
Domain
Human medicine
Field of application
Hypertonie

Package details

Description (FR)
EBRANTIL sol inj 50 mg/10ml 5 amp 10 ml
Description (DE)
EBRANTIL Inj Lös 50 mg/10ml 5 Amp 10 ml
Market launch
21/07/1983
Narcotic (BTM)
No

Other package sizes (1)

None
5 x 5 mL AMP
GTIN: None
Not in V1